Cortellis Competitive Intelligence

Cortellis Competitive Intelligence is an end‑to‑end pharma competitive intelligence platform that helps life sciences organizations make confident portfolio and business development decisions across global markets.

Cortellis Competitive Intelligence provides the broadest and deepest biopharma pipeline intelligence, covering 3,000+ diseases – including rare and niche indications – across global geographies. Unlike other tools, Cortellis offers more early‑phase data, enabling users to identify competitor programs sooner and act on early‑stage partnering or investment opportunities. Integrated access to Cortellis regulatory, clinical, patent, deal and generics data creates a single source of truth for competitive intelligence.

Cortellis Competitive Intelligence is trusted by leading life sciences organizations, including Top 50 global pharma companies, emerging biotech firms, and specialized pharmaceutical competitive intelligence teams, as well as investment professionals.

Cortellis Competitive Intelligence is ideal for professionals in portfolio strategy, licensing and business development, competitive intelligence, and R&D investment planning who need accurate, timely insights to guide high‑stakes decisions. It supports users across commercial, medical and R&D functions who rely on biopharma competitive intelligence to track competitors, prioritize pipelines and validate market opportunities.

Leading life sciences organizations choose Cortellis Competitive Intelligence because it delivers broader, deeper pharma competitive intelligence and more advanced, proven analytics.

Compared to other competitive intelligence solutions, Cortellis Competitive Intelligence offers:

• Unmatched early pipeline coverage for discovery and preclinical programs.
• Proprietary predictive analytics like Drug Timeline & Success Rates, proven to be 35%+ more accurate than standard industry benchmarks.
• Integrated insights across pipeline, regulatory, clinical, deal, and patent data in one platform.
• Granular filtering that enable faster, more precise analysis.

Cortellis Competitive Intelligence supports high-impact decisions such as prioritizing therapeutic areas, evaluating in-licensing or partnering opportunities, and identifying high potential early stage assets. It also helps teams plan for competitor launches, optimize portfolio and resource allocation, and build more accurate forecasts by grounding strategy in comprehensive, curated pipeline, clinical, regulatory, deal, and patent intelligence.

Cortellis Competitive Intelligence includes advanced predictive analytics through our patented Drug Timeline & Success Rates (DT&SR) tool, which uses a proprietary machine learning‑driven algorithm built on more than 22 years of curated Cortellis data.

The DT&SR tool forecasts drug development timelines and likely launch dates, as well as phase‑by‑phase probabilities of success for individual assets. It also supports competitive benchmarking for major milestones with region‑specific predictions across markets such as the US, EU, Japan, China, Singapore and South Korea. Predictions automatically refresh with the latest insights to reflect real-time shifts in the development landscape, enabling proactive scenario planning for asset strategy, competitive tracking, and partnership valuations. ​

Cortellis Competitive Intelligence comprehensive pharma competitive intelligence data that is expertly curated and harmonized into a single, unified platform, giving life sciences teams a current, consistent view of the market.

Cortellis Competitive Intelligence brings together drug and company intelligence, clinical trial outcomes, patent filings, deal activity, proprietary drug sales and forecast data, and more in one solution for end‑to‑end competitive analysis. Data is continuously updated from global sources so users have the latest insights for biopharma competitive intelligence, due diligence, licensing evaluations, and portfolio strategy decisions.

Yes, Cortellis Competitive Intelligence data can be delivered as bulk data via feeds or APIs so you can power internal analytics, dashboards and enterprise applications with trusted pharma competitive intelligence.